 |
|
Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity
Min-Sun Kwak, Donghee Kim
Korean J Intern Med. 2018;33(1):64-74. Published online 2017 Dec 6 DOI: https://doi.org/10.3904/kjim.2017.343
|
|
Citations to this article as recorded by
 Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin
Current Drug Therapy.2024; 19(1): 20. CrossRef Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation
Kishan Dev Pithani, Radhika Vadhi
Arab Journal of Gastroenterology.2024; 25(1): 1. CrossRef Socioeconomic status and health disparities drive differences in accelerometer-derived physical activity in fatty liver disease and significant fibrosis
Lucia Tabacu, Sajag Swami, Mark Ledbetter, Mohamad S. Siddiqui, Ekaterina Smirnova, Rodrigo Yáñez-Sepúlveda
PLOS ONE.2024; 19(5): e0301774. CrossRef Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, Francesco Giovinazzo
Biomedicines.2024; 12(2): 397. CrossRef Association Between Different Types of Physical Activity and Hepatic Steatosis and Liver Fibrosis
Bo Sun, Ying Kang, Junming Zhou, Ying Feng, Wutao Wang, Xiaowei Wu, Xiaohua Zhang, Minli Li
Journal of Clinical Gastroenterology.2024;[Epub] CrossRef The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial
Asal Neshatbini Tehrani, Behzad Hatami, Ghazal Daftari, Azita Hekmatdoost, Zahra Yari, Amin Salehpour, Seyed Ahmad Hosseini, Bizhan Helli
BMC Public Health.2024;[Epub] CrossRef Physical exercise and its effects on liver aminotransferases in non-alcoholic fatty liver disease: a review systematic
Mariana S. SILVA, Felipe N. SANTOS, Laura S. LAGARES, Rodrigo C. MACEDO, Eric S. BOMFIM, Juliana L. SILVA, Luiz A. ALMEIDA, Iasmyn S. SILVA, Clarcson P. SANTOS
Gazzetta Medica Italiana Archivio per le Scienze Mediche.2024;[Epub] CrossRef Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
Wafaa Mohamed Ezzat
World Journal of Gastroenterology.2024; 30(20): 2633. CrossRef The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus
Monika Bhardwaj, Papiya Mitra Mazumder
Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(11): 8421. CrossRef Impact of Physical Activity on Overall Survival and Liver Cirrhosis Incidence in Steatotic Liver Disease: Insights from a Large Cohort Study Using Inverse Probability of Treatment Weighting
Keungmo Yang, Beom Sun Chung, Tom Ryu
Nutrients.2024; 16(15): 2532. CrossRef Metformin: Beyond Type 2 Diabetes Mellitus
Rahnuma Ahmad, Mainul Haque
Cureus.2024;[Epub] CrossRef Metabolic dysfunction-associated steatotic liver disease: a narrative review of pathophysiology, diagnosis, and management
Vignesh Murugan
IP Journal of Nutrition, Metabolism and Health Science.2024; 7(3): 110. CrossRef Regulatory, diagnostic, and therapeutic roles of microRNAs in chronic liver diseases
Razieh Kazemzadeh, Maryam Kheirollahi, Seyed Ali Mard, Akram Ahangarpour, Feryal Savari
Acta Gastro Enterologica Belgica.2024; 87(3): 403. CrossRef The Impact of Aerobic and Anaerobic Exercise Interventions on the Management and Outcomes of Non-Alcoholic Fatty Liver Disease
F Qi, T Li, Q Deng, A Fan
Physiological Research.2024; (5/2024): 671. CrossRef Challenges in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD): Towards a Compassionate Approach
Sue Shea, Christos Lionis, Chris Kite, Lou Atkinson, Lukasz Lagojda, Surinderjeet S. Chaggar, Ioannis Kyrou, Harpal S. Randeva
Livers.2023; 3(3): 434. CrossRef Extraction, purification, structural characterization, and hepatoprotective effect of the polysaccharide from purple sweet potato
Chenjing Li, Yihua Feng, Jingyao Li, Rui Lian, Liehao Qin, Chunling Wang
Journal of the Science of Food and Agriculture.2023; 103(4): 2196. CrossRef Effect of aerobic exercise on GRP78 and ATF6 expressions in mice with non-alcoholic fatty liver disease
Junhan Li, Lei Huang, Wei Xiong, Chun Gu, Shuling Zhang, Xiali Xue
Sports Medicine and Health Science.2023; 5(2): 112. CrossRef Bidirectional association between NAFLD and gallstone disease: a systematic review and meta-analysis of observational studies
Shengying Gu, Shanshan Hu, Shuowen Wang, Chendong Qi, Chenyang Shi, Guorong Fan
Expert Review of Gastroenterology & Hepatology.2023; 17(3): 283. CrossRef Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis
Vikash Jaiswal, Song Peng Ang, Helen Huang, Navroop Kaur Momi, Maha Hameed, Sidra Naz, Nitya Batra, Angela Ishak, Neel Doshi, Asmita Gera, Medha Sharath, Madeeha Subhan Waleed, Nishchita Raj, Victor Hugo Aguilera Alvarez
Journal of Investigative Medicine.2023; 71(6): 591. CrossRef Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular Diseases
Daqing Zhang, Zhen Mi, Jiya Peng, Tiangui Yang, Yuze Han, Yujia Zhai, Chenliang Song, Xianzhuo Teng, Wei Sun, Jing Guo, Kabeya Paulin Bilonda
Journal of Cardiovascular Pharmacology.2023; 81(5): 327. CrossRef Prebiotics and Probiotics: Effects on Dyslipidemia and NAFLD/NASH and the Associated Mechanisms of Action
Alicia Rodríguez-Pastén, Eduardo Fernández-Martínez, Nury Pérez-Hernández, Luis E. Soria-Jasso, Raquel Cariño-Cortés
Current Pharmaceutical Biotechnology.2023; 24(5): 633. CrossRef Physical Activity Protocols in Non-Alcoholic Fatty Liver Disease Management: A Systematic Review of Randomized Clinical Trials and Animal Models
Elisa Barrón-Cabrera, Raúl Soria-Rodríguez, Fernando Amador-Lara, Erika Martínez-López
Healthcare.2023; 11(14): 1992. CrossRef Early Identification of Risk Factors in Non-Alcoholic Fatty Liver Disease (NAFLD) Using Machine Learning
Luis Rolando Guarneros-Nolasco, Giner Alor-Hernández, Guillermo Prieto-Avalos, José Luis Sánchez-Cervantes
Mathematics.2023; 11(13): 3026. CrossRef Aerobic and Resistance Exercise: Synergistic Influence for Nonalcoholic Fatty Liver Disease
Ho Soo Chun
Gut and Liver.2023; 17(4): 485. CrossRef Association between handgrip strength, nonalcoholic fatty liver disease, advanced hepatic fibrosis and its modifiers: Evidence from the NHANES database of the USA
Xiaohong Zhao, Xuexue Shi, Haifeng Gu, Wenjing Zhou, Qin Zhang
Journal of Gastroenterology and Hepatology.2023; 38(10): 1734. CrossRef Unravelling the Interplay: Exploring the Influence of Previous Hepatitis B Virus, Hepatitis A Virus, and Hepatitis E Virus Infections on Non-alcoholic Fatty Liver Disease
Vinay Narladkar, Aman Agrawal, Sanket S Bakshi, Swarupa Chakole, Aniket G Pathade, Seema Yelne
Cureus.2023;[Epub] CrossRef Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations
Angela Di Porzio, Valentina Barrella, Cristina Gatto, Luisa Cigliano, Maria Stefania Spagnuolo, Raffaella Crescenzo, Ida Romano, Gianluigi Mauriello, Susanna Iossa, Arianna Mazzoli
Journal of Functional Foods.2023; 109: 105805. CrossRef Az ómega-3 zsírsavak jelentősége a nem alkoholos zsírmájbetegség kezelésében
Rebeka Anna Makó, Anna Egresi, Anna Blázovics, Réka Oszlányi, Krisztina Hagymási
Orvosi Hetilap.2023; 164(33): 1294. CrossRef Allopurinol versus Febuxostat: A New Approach for the Management of Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Amani Al-Shargi, Amal A. El Kholy, Abdulmoneim Adel, Mohamed Hassany, Sara M. Shaheen
Biomedicines.2023; 11(11): 3074. CrossRef Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan
Donghee Kim, Peter Konyn, George Cholankeril, Aijaz Ahmed
Clinical Gastroenterology and Hepatology.2022; 20(6): e1438. CrossRef The effects of voluntary wheel running during weight-loss on biomarkers of hepatic lipid metabolism and inflammation in C57Bl/6J mice
Joshua S. Wooten, Kaylee E. Poole, Matthew P. Harris, Brianne L. Guilford, Megan L. Schaller, David Umbaugh, Andrew Seija
Current Research in Physiology.2022; 5: 63. CrossRef Interrelationship between physical activity and depression in nonalcoholic fatty liver disease
Ali A Weinstein, Leyla De Avila, Saisruthi Kannan, James M Paik, Pegah Golabi, Lynn H Gerber, Zobair M Younossi
World Journal of Hepatology.2022; 14(3): 612. CrossRef The Association Between Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease Diagnosis Varies by Race
Rohan Mahabaleshwarkar, Tsai-Ling Liu, Iain H. McKillop, Melanie Spencer
Metabolic Syndrome and Related Disorders.2022;[Epub] CrossRef Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals
Azizullah Beran, Hazem Ayesh, Mohammed Mhanna, Waseem Wahood, Sami Ghazaleh, Ziad Abuhelwa, Wasef Sayeh, Nameer Aladamat, Rami Musallam, Reem Matar, Saif-Eddin Malhas, Ragheb Assaly
Journal of Clinical Medicine.2022; 11(9): 2666. CrossRef Comparing the Efficacy and Safety of Obeticholic Acid and Semaglutide in Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review
Nabeel R Ahmed, Vaishnavi Vijaya Kulkarni, Sushil Pokhrel, Hamna Akram, Arowa Abdelgadir, Abanti Chatterjee, Safeera Khan
Cureus.2022;[Epub] CrossRef The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults
Hossein Farhadnejad, Asal Neshatbini Tehrani, Mitra Kazemi Jahromi, Farshad Teymoori, Ebrahim Mokhtari, Ammar Salehi-Sahlabadi, Parvin Mirmiran
BMC Gastroenterology.2022;[Epub] CrossRef Investigation of movement-related behaviors and energy compensation in people living with liver disease: A scoping review
Carminda Goersch Lamboglia, Ashley P. Mccurdy, Yeong-Bae Kim, Cliff Lindeman, Amie J. Mangan, Allison Sivak, Diana Mager, John C. Spence
Journal of Sports Sciences.2022; 40(12): 1299. CrossRef Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis, Michail Pitiakoudis
Current Oncology.2022; 29(7): 4478. CrossRef A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease
Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Sofía Montemayor, Catalina M. Mascaró, Miguel Casares, Isabel Llompart, José M. Gámez, Silvia Tejada, J. Alfredo Martínez, Josep A. Tur, Antoni Sureda
Antioxidants.2022; 11(7): 1266. CrossRef Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity
Valeria Calcaterra, Vittoria Magenes, Matteo Vandoni, Clarissa Berardo, Luca Marin, Alice Bianchi, Erika Cordaro, Giustino Silvestro, Dario Silvestri, Vittoria Carnevale Pellino, Cristina Cereda, Gianvincenzo Zuccotti
Children.2022; 9(8): 1174. CrossRef Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice
Mingjuan Liao, Rong Zhang, Yongling Wang, Ziming Mao, Jing Wu, Huaqi Guo, Kaiwen Zhang, Yu Jing, Caoxu Zhang, Huaidong Song, Xia Chen, Gang Wei
Frontiers in Nutrition.2022;[Epub] CrossRef The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients
Sahar H. Elhini, Engy A. Wahsh, Ahmed A. Elberry, Nadia F. El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A. Elsayed, Hoda M. Rabea
Pharmaceuticals.2022; 15(12): 1516. CrossRef Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen
Nutrients.2022; 14(21): 4556. CrossRef Physical activity and liver health among urban and rural Chinese adults: results from two independent surveys
Yan Chen, Ying Chen, Baohua Geng, Yong Zhang, Rui Qin, Yamei Cai, Feng Bai, Dahai Yu
Journal of Exercise Science & Fitness.2021; 19(1): 8. CrossRef Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non‐alcoholic fatty liver disease: A double‐blind randomized controlled clinical trial
Fatemeh Izadi, Amirhosein Farrokhzad, Babak Tamizifar, Mohammad Javad Tarrahi, Mohammad Hassan Entezari
Phytotherapy Research.2021; 35(1): 477. CrossRef Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials
Sahar Rafiee, Hamed Mohammadi, Abed Ghavami, Erfan Sadeghi, Zahra Safari, Gholamreza Askari
Complementary Therapies in Clinical Practice.2021; 42: 101281. CrossRef A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia, Mohammadreza Farzanehfar
Journal of Gastroenterology and Hepatology.2021; 36(6): 1497. CrossRef Recommended Musculoskeletal and Sports Medicine Curriculum for Internal Medicine Residency Training
David G. Liddle, Bradley Changstrom, Carlin Senter, Paul Meirick, Nicole Stern, Margot Putukian, Selina Shah, Amy Powell, Sameer Dixit, Kevin Eerkes, Byron Moran, Kenneth P. Barnes, Claudia Dal Molin, Rebecca Myers, Anna L. Waterbrook
Current Sports Medicine Reports.2021; 20(2): 113. CrossRef The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Reem Abou Assi, Ibrahim M. Abdulbaqi, Chan Siok Yee
Pharmaceuticals.2021; 14(3): 215. CrossRef Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease
Donghee Kim, Soumya Murag, George Cholankeril, Amanda Cheung, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed
Clinical Gastroenterology and Hepatology.2021; 19(6): 1240. CrossRef Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry
Jun Sik Yoon, Han Ah Lee, Hwi Young Kim, Dong Hyun Sinn, Dong Ho Lee, Suk Kyun Hong, Ju-Yeon Cho, Jonggi Choi, Young Chang, Hyun-Joo Kong, Eunyang Kim, Young-Joo Won, Jeong-Hoon Lee
Journal of Liver Cancer.2021; 21(1): 58. CrossRef Physical Comorbidity According to Diagnoses and Sex among Psychiatric Inpatients in South Korea
Suin Park, Go-Un Kim, Hyunlye Kim
International Journal of Environmental Research and Public Health.2021; 18(8): 4187. CrossRef Association between toothbrushing and non-alcoholic fatty liver disease
Ji-Youn Kim, Yong-Moon Park, Gyu-Na Lee, Hyun Chul Song, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko, Houkai Li
PLOS ONE.2021; 16(5): e0243686. CrossRef Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018
Gary A. Abrams, Anna M. Rabil, Ana-Ysabel P. Williams, Eric M. Hecht
Clinical Pediatrics.2021; 60(8): 370. CrossRef Effect of Silymarin Supplementation in Lung and Liver Histological Modifications during Exercise Training in a Rodent Model
Nancy Vargas-Mendoza, Marcelo Angeles-Valencia, Ángel Morales-González, Mauricio Morales-Martínez, Eduardo Madrigal-Bujaidar, Isela Álvarez-González, Tomás Fregoso-Aguilar, Luis Delgado-Olivares, Eduardo Osiris Madrigal-Santillán, José A. Morales-González
Journal of Functional Morphology and Kinesiology.2021; 6(3): 72. CrossRef A qualitative study of self‐management experiences in people with non‐alcoholic fatty liver disease
Yeonsoo Jang, Ji Yea Lee, Seung Up Kim, Beomkyung Kim
Nursing Open.2021; 8(6): 3135. CrossRef Non-alcoholic fatty liver disease: A patient guideline
Sven M. Francque, Giulio Marchesini, Achim Kautz, Martine Walmsley, Rebecca Dorner, Jeffrey V. Lazarus, Shira Zelber-Sagi, Kate Hallsworth, Luca Busetto, Gema Frühbeck, Dror Dicker, Euan Woodward, Marko Korenjak, José Willemse, Gerardus H. Koek, Shlomo Vi
JHEP Reports.2021; 3(5): 100322. CrossRef The prevalence of disorders of the gut-brain axis in type 2 diabetes mellitus patients with metabolic dysfunction-associated fatty liver disease: an observational study
T Van Nieuwenhove, G Rasschaert, A Kharagjitsingh, B Keymeulen, H Reynaert, S Kindt
Acta Gastro Enterologica Belgica.2021; 84(4): 541. CrossRef Decreased Physical Working Capacity in Adolescents With Nonalcoholic Fatty Liver Disease Associates With Reduced Iron Availability
Tim Mitchell, Elizabeth McKinnon, Oyekoya Ayonrinde, Leon A. Adams, Debbie Trinder, Anita C.G. Chua, Robert U. Newton, Leon Straker, John K. Olynyk
Clinical Gastroenterology and Hepatology.2020; 18(7): 1584. CrossRef Prevalencia del hígado graso no alcohólico y su asociación con alteraciones bioquímicas en una población mexicana asintomática
Enrique Díaz Greene, Federico Rodríguez Weber, Georgina Cornelio Rodríguez, María José Ortega Chavarría
Acta Médica Grupo Ángeles.2020; 18(2): 127. CrossRef Dietary Intervention Accelerates NASH Resolution Depending on Inflammatory Status with Minor Additive Effects on Hepatic Injury by Vitamin E Supplementation
Julie Hviid Klaebel, Günaj Rakipovski, Birgitte Andersen, Jens Lykkesfeldt, Pernille Tveden-Nyborg
Antioxidants.2020; 9(9): 808. CrossRef Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV
Jovana Milic, Valentina Menozzi, Filippo Schepis, Andrea Malagoli, Giulia Besutti, Iacopo Franconi, Alessandro Raimondi, Federica Carli, Cristina Mussini, Giada Sebastiani, Giovanni Guaraldi
AIDS.2020; 34(13): 1915. CrossRef Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease
Donghee Kim, Luis Miguel Vazquez‐Montesino, Andrew A. Li, George Cholankeril, Aijaz Ahmed
Hepatology.2020; 72(5): 1556. CrossRef Resistance Exercise Regulates Hepatic Lipolytic Factors as Effective as Aerobic Exercise in Obese Mice
Ju Yong Bae
International Journal of Environmental Research and Public Health.2020; 17(22): 8307. CrossRef Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial
Isabella Franco, Antonella Bianco, Antonella Mirizzi, Angelo Campanella, Caterina Bonfiglio, Paolo Sorino, Maria Notarnicola, Valeria Tutino, Raffaele Cozzolongo, Vito Giannuzzi, Laura R. Aballay, Claudia Buongiorno, Irene Bruno, Alberto R. Osella
Nutrients.2020; 13(1): 66. CrossRef Dietary patterns are associated with the prevalence of nonalcoholic fatty liver disease in Korean adults
Goh Eun Chung, Jiyoung Youn, Young Sun Kim, Jung Eun Lee, Sun Young Yang, Joo Hyun Lim, Ji Hyun Song, Eun Young Doo, Joo Sung Kim
Nutrition.2019; 62: 32. CrossRef Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study
Jae-Uk Song, Yoonjung Jang, Si-Young Lim, Seungho Ryu, Won Jun Song, Christopher D. Byrne, Ki-Chul Sung, Giovanni Targher
PLOS ONE.2019; 14(1): e0208736. CrossRef Consenso mexicano de la enfermedad por hígado graso no alcohólico
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrer
Revista de Gastroenterología de México.2019; 84(1): 69. CrossRef The Mexican consensus on nonalcoholic fatty liver disease
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrer
Revista de Gastroenterología de México (English Edition).2019; 84(1): 69. CrossRef Aerobic capacity and exercise performance in nonalcoholic fatty liver disease
Patrick Austin, Lynn Gerber, James M. Paik, Jillian K. Price, Carey Escheik, Zobair M. Younossi
The Journal of Sports Medicine and Physical Fitness.2019;[Epub] CrossRef Vibrational spectroscopy-based quantification of liver steatosis
E. Szafraniec, S. Tott, E. Kus, D. Augustynska, A. Jasztal, A. Filipek, S. Chlopicki, M. Baranska
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2019; 1865(11): 165526. CrossRef Exercise Programming for Nonalcoholic Fatty Liver Disease
Tom Cormier
Strength & Conditioning Journal.2019; 41(4): 89. CrossRef Non‐alcoholic fatty liver disease (NAFLD)—Treat to target, but the goalposts are in the wrong place
Stephen Malnick, Ehud Melzer, Yaakov Maor
GastroHep.2019; 1(5): 203. CrossRef Lifestyle modification in NAFLD/NASH: Facts and figures
Kate Hallsworth, Leon A. Adams
JHEP Reports.2019; 1(6): 468. CrossRef Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen
Nutrients.2019; 11(12): 2878. CrossRef Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment
Ming-Ming Chen, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li
Gene Expression.2019; 19(3): 175. CrossRef
|